The fund’s strategy, top holdings, and recent portfolio moves are explored to provide insights for existing and potential investors.

The fund’s strategy, top holdings, and recent portfolio moves are explored to provide insights for existing and potential investors.

The change is perceptible in all corners of the market. But let’s start with equities. In the months running up to the ...

Several individual small-caps shone but the S&P/ASX Small Ordinaries Index underperformed the ASX 200. The post 3 ASX ...

We reveal the 16 best ASX 200 large-cap stocks for share price growth last year. The post Which ASX 200 large-cap shares ...

With such a wide range of potential outcomes this year, risk management and value capture will be important themes.

Investors are watching to see if technology companies and related heavyweights will add to recent strong profit gains and ...

We recently compiled a list of the 12 Best Technology Stocks to Invest In for the Long Term. In this article, we are going to ...

The biggest US tech stocks have enjoyed an earnings bonanza in the past two years, leading to their significant ...

JP Morgan highlights mixed sentiment for U.S. large-cap biopharma stocks as advancements in obesity drugs and key product launches shape 2025 outlook.

Heading into the end of the year, the investment market has given us and our clients plenty to be thankful for Even so, more ...

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” fourth ...